Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-30 @ 4:20 PM
Study NCT ID:
NCT04517357
Status:
COMPLETED
Last Update Posted:
2025-02-24
First Post:
2020-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-16
First Submit QC Date:
None
Study First Post Date:
2020-08-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-02-24
Last Update Post Date Type:
ACTUAL